## Abstract Twentyโone children (19 with leukemia) were given 34 courses of vindesine on a weekly or twiceโweekly schedule in escalating doses. Thirtyโthree courses were fully or partially evaluable for response and/or toxicity. Granulocytoโpenia was the doseโlimiting toxicity. Transient jaw, neck,
โฆ LIBER โฆ
Evaluation of Melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study
โ Scribed by Robert T. Dorr; Ruskin Lines; Norman Levine; Christine Brooks; Li Xiang; Victor J. Hruby; Mac E. Hadley
- Book ID
- 116019069
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 596 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0024-3205
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Phase I evaluation of vindesine in child
โ
Komp, Diane ;Vats, Tribhawan ;Shepherd, Dell A. ;Vietti, Teresa ;Hoogstraten, Ba
๐
Article
๐
1980
๐
John Wiley and Sons
๐
English
โ 374 KB
Vaccination with HPV16 peptides of patie
โ
W.J. van Driel; M.E. Ressing; G.G. Kenter; R.M.P. Brandt; E.J.T. Krul; A.B. van
๐
Article
๐
1999
๐
Elsevier Science
๐
English
โ 114 KB
A Phase II Pilot Study to Evaluate Use o
โ
Shekhar Sharma; M.R. Rajagopal; Gayatri Palat; Charu Singh; Altaf G. Haji; Dimpe
๐
Article
๐
2009
๐
Elsevier Science
๐
English
โ 556 KB
Phase I Clinical Evaluation of Carboplat
โ
W.C. Kisseberth; D.M. Vail; J. Yaissle; K.A. Jeglum; C.G. Couto; H. Ward; C. Kha
๐
Article
๐
2008
๐
John Wiley and Sons
๐
English
โ 102 KB
[ 99m Tc]Demotensin VI: Biodistribution
โ
Gabriel, Michael; Decristoforo, Clemens; Wรถll, Ewald; Eisterer, Wolfgang; Nock,
๐
Article
๐
2011
๐
Mary Ann Liebert
๐
English
โ 253 KB
Ex vivo ras peptide vaccination in patie
โ
Marianne K. Gjertsen; Arne Bakka; Jarle Breivik; Ingvil Saeterdal; Tobias Gedde-
๐
Article
๐
1996
๐
John Wiley and Sons
๐
French
โ 434 KB
๐ 2 views
In a pilot phase 1/11 study we have tested synthetic ras peptides used as a cancer vaccine in 5 patients with advanced pancreatic carcinoma. The treatment principle used was based on loading professional antigen-presenting cells (APCs) from peripheral blood with a synthetic ras peptide corresponding